XML 40 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue and Accounts Receivable Credit Concentration (Tables)
3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Summary of Revenue

Revenues consisted of the following (in thousands):

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

Diagnostic tests

 

$

8,645

 

 

$

5,633

 

Services

 

 

411

 

 

 

915

 

Total revenue

 

$

9,056

 

 

$

6,548

 

Summary of Revenue and Accounts Receivable by Third-party Payors and Other Customers

The Company’s customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows:

 

 

Three Months Ended March 31,

 

 

 

2023

 

 

2022

 

United Healthcare

 

 

11

%

 

 

 

The Company’s third-party payors and other customers in excess of 10% of accounts receivable, and their related accounts receivable as a percentage of total accounts receivable were as follows:

 

 

As of

 

 

 

March 31, 2023

 

 

December 31, 2022

 

Medicare

 

 

20

%

 

 

23

%

AstraZeneca UK

 

 

20

%

 

 

18

%